Boston Scientific Corporation
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston Scientific Corporation sits in the top decile of US sponsors by registered trial count (#122 of 15,742 sponsors by registered trial count).
Boston Scientific Corporation: 280 sponsored US clinical trials, 22 recruiting.
Boston Scientific Corporation sponsors 280 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 207 completed. 59 of these trials are in Phase 3-4 (later-stage) and 23 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 8 trials.
Top-decile sponsor footprint
Boston Scientific Corporation ranks in the top decile of sponsors by registered trial count (#122 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
207 of 239 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
280 total, page 5 of 6
PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)
NCT01510327
Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy
NCT00947310
Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
NCT00955708
An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose Veins
NCT00928421
EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries
NCT00896337
Optimized Programming in Spinal Cord Stimulation (SCS) System
NCT00871819
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT01498692
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)
NCT01500434
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
NCT00823212
Evaluation of Left Ventricular AutoThreshold
NCT00812201
A Carotid Stenting Boston Scientific Surveillance Program
NCT00741091
APPROPRIATE - Rate Adaptive Pacing Sensor
NCT00757666
Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients
NCT00758121
Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence
NCT00758420
Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction
NCT00670111
Investigating Superion™ In Spinal Stenosis
NCT00692276
Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy (CRT)
NCT00677014
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
NCT00573131
A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation
NCT00528021
TAXUS PERSEUS Workhorse
NCT00484315
TAXUS PERSEUS Small Vessel
NCT00489541
Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA
NCT00478673
A Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction
NCT00433771
Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt
NCT00442364
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
NCT00479765
Spinal Cord Stimulation for Painful Diabetic Neuropathy
NCT00487981
Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain
NCT00418301
TheraSphere for the Treatment of Liver Metastases
NCT00511862
The Prefyx PPS™ System eRegistry
NCT00688181
Spy II Clinical Registry
NCT00751998
Effect of Pulse Width With Spinal Cord Stimulation
NCT00399516
Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity
NCT00399841
Effectiveness of Precision Spinal Cord Stimulation With Artisan Paddle Electrode
NCT00386724
Efficacy of the Spinal Cord Stimulation System as Salvage Therapy
NCT00387244
TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?
NCT00344630
RAPID-RF: Remote Active Monitoring in Patients With Heart Failure
NCT00334451
REASSURE AV Registry
NCT01074034
EASYTRAK 3 Downsize Lead
NCT00384722
Treatment for Migraines With an Implantable Device
NCT00286078
Spinal Cord Stimulation for Chronic and Intractable Back Pain
NCT00370695
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
NCT00628901
Comparison of Intraspinal Nerve Root Stimulation With Dorsal Column Stimulation
NCT00370773
First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data
NCT01161589
Asthma Intervention Research 2 (AIR2) Trial
NCT00231114
ULTRA Study for Pacemaker Patients
NCT00133289
RIGHT: Rhythm ID Going Head-to-Head Trial
NCT00148954
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
NCT00111488
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
NCT00605631
EASYTRAK 4 Steerable LV Lead
NCT00158964
Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions
NCT00371423
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 16 |
| Phase 3 | 33 |
| Phase 4 | 26 |
Therapeutic Areas
Where Boston Scientific Corporation enrollment is open (later-stage tilt)
22 recruiting of 280 indexed (8% open); 207 completed (74%).
Phase mix: 59 late (III/IV) vs 23 early (I/II) (later-stage heavy).
Top condition: Coronary Artery Disease (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston Scientific Corporation: open-pipeline peers nationwide
Peers matched on 280 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
Boston Scientific Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 280 trials (± recruiting share)
- Regeneron Pharmaceuticals · 280 trials · 22% recruiting
- Alcon Research · 275 trials · 2% recruiting
- Eisai · 287 trials · 2% recruiting
- SWOG Cancer Research Network · 270 trials · 10% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 8% recruiting · 305 trials
- Novo Nordisk A/S · 8% recruiting · 431 trials
- Hoffmann-La Roche · 8% recruiting · 909 trials
- United Therapeutics · 8% recruiting · 63 trials
Related
What to do with this Boston Scientific Corporation page
280 registered trials is a research-attention snapshot, not an endorsement of Boston Scientific Corporation or any single study.
- 22 of Boston Scientific Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition Boston Scientific Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Boston Scientific Corporation pipeline card: 280 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.